Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
ESC Heart Failure|September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MIDavid Erlinge, Stefan James, John Deanfield, et al.
Circulation. Genomic and Precision Medicine|March 2, 2021
Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease PredictionFernando Riveros-Mckay, Michael E Weale, Rachel Moore, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart FailureStefan James, David Erlinge, Robert F Storey, et al.
Circulation. Cardiovascular Genetics|January 1, 2013
Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysisSonia Shah, Juan-Pablo Casas, Fotios Drenos, et al.
Lancet (London, England)|October 25, 2025
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialJohn Deanfield, A Michael Lincoff, Steven E Kahn, et al.
American Journal of Physiology. Renal Physiology|October 14, 2016
The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetesKevin D Burns, Yuliya Lytvyn, Farid H Mahmud, et al.
Nature Medicine|May 13, 2024
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trialDonna H Ryan, Ildiko Lingvay, John Deanfield, et al.
JACC. Cardiovascular Imaging|March 7, 2023
Deep-Learning for Epicardial Adipose Tissue Assessment With Computed Tomography: Implications for Cardiovascular Risk PredictionHenry W West, Muhammad Siddique, Michelle C Williams, et al.
Pageof 19